Cancer. That one word has the power to create great fear. Why is that? Maybe it's because it can hide and grow for some time before it is detected. Or maybe it's the thought that even if surgery or chemo gets rid of most of it, even if one cell is left, it came come back. Then there are the stories we've heard from friends or relatives who have experienced the negative side effects of cancer treatment - hair falling out, nausea vomiting, weight loss - the "wasting away" of the body.
A cancer is built to survive. CA (cancer) cells are covered with fibrin (the same stuff scar tissue is made of). As the cells grab onto one another to form tumors, these growths themselves are armored with fibrin. This thick protective coating is designed to prevent the body's own defenses (i.e., natural killer cells, white blood cells or oxygen) from getting inside the cell or tumor to destroy it. It is this same defense that keeps chemotherapy out of the cells in all but industrial strength doses. (Doses that are just as likely to kill the patient as the cancer.)
Would it not make sense to have something strip away the outer fibrous wall of CA so that whatever agents we are using as medicine, whether natural or otherwise, can actually get into the cell and do their job? Doctors in Europe and Asia have been treating cancers with highly fibrinolytic enzymes (scar tissue eating enzymes) and getting better results with treating cancer for almost 30 years.
In Germany and Japan enzymes were being used by orthodox medical researchers to augment established therapy. It was found that by introducing a strongly fibrinolytic enzyme like chymotrypsin or serrapeptase that anti-cancer medications penetrated the cancer cell easier. Therefore, lower dosages of chemotherapy could be used and high levels of toxicity in the patient could be avoided. Along with that, researchers found that the enzymes seemed to reduce the side effects of the chemotherapy and, definitely reduced the debilitating muscle wasting that chemo therapy produced in its patients.
In radiation therapy patients, these doctors found that taking systemic enzymes after treatments reduced the fibrosis that grew in the treated organs. Organs treated with radiation become very hard filled with scar tissue, which restricts the organ and reduces its overall function. The enzymes were found to prevent a good bit of that scaring from occurring and where it had already happened, the enzymes reduced existing fibrosis. The use of orally administered systemic enzymes to aid in the treatment of cancer was embraced by these countries.
After decades of resistance, systemic enzyme therapy as an adjunct to overall cancer treatment has finally gained a foothold in America. Wholistic and alternative cancer treatment centers, as well as some oncologists, are using enzymes to assist in the fight against the disease.
Trypsin and Chymotrypsin
Dr. Heinrich Wrba, a leading European oncolologist, has quietly and permanently changed the way cancer is treated throughout Europe. He has educated a generation of European oncologists on the value of systemic oral enzymes in the treatment of cancer. "Using 20 to 30 tablets twice daily of Wobenzym® N, we see improvement," Dr. Wrba says. "I have seen about one-third of cases of pancreatic cancer that were completely cured with about two-thirds not responding well, which for this cancer is an excellent outcome. Based on experience, the outcome for most patients is improved with systemic oral enzyme therapy. Enzymes rank as my favorite adjuvant medicine for every type of cancer. It is very essential to take them in very high doses. We can force a beneficial effect at 30 pills three times daily."
As mentioned earlier, chymotrypsin (and trypsin) and serrapeptase are specific proteolytic enzymes that are especially effective with cancer. Chymotrypsin has ingredients that reduce swelling (inflammation) and tissue destruction and is part of the enzyme blend in Wobenzym® N.
Naturopathic physician Dr. Michael Murray recommends systemic enzyme use in his work "How to Prevent and Treat Cancer With Natural Medicine". To quote from Dr. Murray: "Serratia peptidase exerts more powerful effects than chymotrypsin and trypsin in all of these applications". Serratia peptidase is the same as serrapeptase.
Serrapeptase is a proteolytic enzyme that digests non-living tissue, blood clots, cysts, tumors, and arterial plaque and inflammation in all forms. It is a naturally occurring, physiological agent with no inhibitory effects on prostaglandins and is devoid of gastrointestinal side effects. It is a viable alternative to salicylates, ibuprofen and the more potent NSAIDs.
The late German physician, Dr. Hans Nieper, used serrapeptase to treat arterial blockage in his coronary patients. Serrapeptase protects against stroke and is reportedly more effective and quicker than EDTA Chelation treatments in removing arterial plaque. He also reports that serrapeptase dissolves blood clots and causes varicose veins to shrink or diminish. Dr. Nieper told of a woman scheduled for hand amputation and a man scheduled for bypass surgery who both recovered quickly without surgery after treatment with serrapeptase.
Dr. James Howenstine, M.D. promotes the systemic enzyme blend Vitalzym as being the best enzyme supplement containing serrapeptase. He says, "This potent enzyme product can dissolve the fibrin coating protecting cancer cells from destruction."
Vitalzym works to break down fibrin in the body. Fibrin is a hard, sticky protein that has been associated with scar tissue, inflammation and pain, among other symptoms and conditions. Additionally, Vitalzym can help reduce viral load and regulate the immune system, reduce toxins and impurities in the blood, promote cellular detoxification, reduce internal inflammation, and promote overall better health.
Vitalzym works synergistically to provide total system support. It contains protease, serrapeptase, papain, bromelain, amylase, lipase, rutin and amla. According to Dr. Peter Streichhan, a world-renowned enzyme researcher from Germany, "enzyme mixtures have a wider range of therapeutic advantages than do individual enzymes."
The key to the effectiveness of any systemic enzyme is the amount absorbed into the bloodstream. Vitalzym continues to be at the forefront of enzyme supplementation.
Systemic Enzymes "Activation" Dose
Normally, the recommended dosage given on the label is meant as a maintenance dose for those consumers with minor complaints. Consumers with autoimmune conditions or cancer need to find the dose at which they begin to feel better.
The dose starts with three tablets three times daily on an empty stomach. If in 3 days no benefits are felt, increase the dose to 4 capsules 3 times a day for 3 days. Continue increasing the number of capsules taken until a benefit is felt. Note: Enterically coated systemic enzyme capsules will work at lower doses due to superior survival of the enzymes through the stomach acids.
There is no toxicity from enzymes. Some customers who have suffered accidents have been placed on 10 systemic enzyme capsules 3 times a day by their doctors for a few weeks until the bulk of their inflammation and its resultant pain are gone.
When a systemic enzyme “kicks in”’ there will be no doubt in a person's mind that it is working! The activation dose is the amount of enzymes a person needs to take in order to feel a benefit from the product.
Hemophiliacs and those on prescription blood thinners should not use this or any other systemic enzyme without first consulting with their health professional. As the enzymes help the drugs to work better and may overly thin the blood, hemophiliacs do need to be cautious if using systemic enzymes.
One Final Word
The Wolfe Clinic is proud to say that we search out for the "best of the best" supplements to offer our customers. We offer Wobenzym N that contains chymotrypsin and two products that contain natural chelation-anti-inflammatory serrapeptase: Vitalzym.
The Wolfe Clinic
Rosanova, A.: The present stand of enzyme therapy in the treatment of malignant tumors. Arztl Praxis XVI 36, 1964, 1442-1444.
Konig, W.: Enzyme therapy in the treatment of viral diseases and carcinoma. Erfahrungsheilk. 38, 1989, 455-459.
Desser, L., Ransberger, A.: Introduction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes. Oncology 47, 1990, 475.
Beaufort, E.: Reduction in the adverse effects of radiation therapy with hydrolytic enzymes. Therapeutikon 10, 1990, 577-580.